Insider · CIK 0001752827

Martin Daniel C.

Reports to the SEC for 1 company · WALTHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001752827

Forms 4 and 5

Insider transactions

34 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-06-11	Deciphera Pharmaceuticals, Inc.A Award	Chief Commercial Officer	AAward	+20.2K sh	—	—	75,281
2024-06-11	Deciphera Pharmaceuticals, Inc.D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−44K sh	—	—	31,330
2024-06-11	Deciphera Pharmaceuticals, Inc.U Disposition from Tender	Chief Commercial Officer	UDisposition from Tender	−31.3K sh	—	—	0
2024-06-11	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−63K sh	—	—	0
2024-06-11	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−54.7K sh	—	—	0
2024-06-11	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−44.6K sh	—	—	0
2024-06-11	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−38.9K sh	—	—	0
2024-02-16	Deciphera Pharmaceuticals, Inc.S Sale	Chief Commercial Officer	SSale	−2,267 sh	$15.62	−$35.4K	55,118
2024-02-15	Deciphera Pharmaceuticals, Inc.A Award	Chief Commercial Officer	AAward	+9,725 sh	—	—	57,385
2024-02-15	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Chief Commercial Officer	AAward	+38.9K sh	—	—	38,900
2024-01-16	Deciphera Pharmaceuticals, Inc.S Sale	Chief Commercial Officer	SSale	−1,624 sh	$14.47	−$23.5K	47,660
2023-12-13	Deciphera Pharmaceuticals, Inc.S Sale	Chief Commercial Officer	SSale	−1,727 sh	$15.37	−$26.5K	49,284
2023-12-12	Deciphera Pharmaceuticals, Inc.A Award	Chief Commercial Officer	AAward	+5,576 sh	—	—	51,011
2023-11-30	Deciphera Pharmaceuticals, Inc.S Sale	Chief Commercial Officer	SSale	−17.8K sh	$12.57	−$224K	45,435
2023-10-30	Deciphera Pharmaceuticals, Inc.S Sale	Chief Commercial Officer	SSale	−1,407 sh	$12.02	−$16.9K	62,884
2023-10-28	Deciphera Pharmaceuticals, Inc.A Award	Chief Commercial Officer	AAward	+5,576 sh	—	—	64,291
2023-06-16	Deciphera Pharmaceuticals, Inc.S Sale	Chief Commercial Officer	SSale	−1,238 sh	$14.40	−$17.8K	58,413
2023-02-16	Deciphera Pharmaceuticals, Inc.S Sale	Chief Commercial Officer	SSale	−1,159 sh	$15.10	−$17.5K	58,381
2023-02-15	Deciphera Pharmaceuticals, Inc.A Award	Chief Commercial Officer	AAward	+11.2K sh	—	—	59,540
2023-02-15	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Chief Commercial Officer	AAward	+44.6K sh	—	—	44,600
2023-01-17	Deciphera Pharmaceuticals, Inc.S Sale	Chief Commercial Officer	SSale	−1,603 sh	$21.24	−$34K	48,389
2022-06-16	Deciphera Pharmaceuticals, Inc.S Sale	Chief Commercial Officer	SSale	−1,311 sh	$10.75	−$14.1K	49,521
2022-02-16	Deciphera Pharmaceuticals, Inc.S Sale	Chief Commercial Officer	SSale	−1,146 sh	$9.05	−$10.4K	48,668
2022-01-18	Deciphera Pharmaceuticals, Inc.A Award	Chief Commercial Officer	AAward	+13.7K sh	—	—	49,814
2022-01-18	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Chief Commercial Officer	AAward	+54.7K sh	—	—	54,667
2021-12-15	Deciphera Pharmaceuticals, Inc.A Award	Chief Commercial Officer	AAward	+8,300 sh	—	—	36,147
2021-12-15	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Chief Commercial Officer	AAward	+63K sh	—	—	62,971
2020-01-22	Deciphera Pharmaceuticals, Inc.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+27K sh	$36.10	+$975K	43,999
2020-01-22	Deciphera Pharmaceuticals, Inc.S Sale	Chief Commercial Officer	SSale	−27K sh	$67.18	−$1.81M	17,000
2020-01-22	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)C Conversion	Chief Commercial Officer	CConversion	−27K sh	—	—	63,001
2019-09-19	Deciphera Pharmaceuticals, Inc.S Sale	Chief Commercial Officer	SSale	−3,000 sh	$35.56	−$107K	17,000
2019-01-30	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Chief Commercial Officer	AAward	+52K sh	—	—	52,000
2018-09-18	Deciphera Pharmaceuticals, Inc.A Award	Chief Commercial Officer	AAward	+20K sh	—	—	20,000
2018-09-18	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Chief Commercial Officer	AAward	+90K sh	—	—	90,000

Recent filings

Accepted (ET)
Jun 114
Martin Daniel C.0000950170-24-072209
SEC(opens sec.gov)
Feb 204
Martin Daniel C.0000950170-24-017087
SEC(opens sec.gov)
Jan 184
Martin Daniel C.0000950170-24-005388
SEC(opens sec.gov)
Dec 144
Martin Daniel C.0000950170-23-070383
SEC(opens sec.gov)
Dec 14
Martin Daniel C.0000950170-23-067324
SEC(opens sec.gov)
Oct 314
Martin Daniel C.0001209191-23-053937
SEC(opens sec.gov)
Jun 214
Martin Daniel C.0001209191-23-038754
SEC(opens sec.gov)
Feb 174
Martin Daniel C.0001209191-23-010544
SEC(opens sec.gov)

Companies

Deciphera Pharmaceuticals, Inc.Chief Commercial Officer

Address

C/O DECIPHERA PHARMACEUTICALS, INC. 500 TOTTEN POND ROAD

WALTHAM, MA, 02451